Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial 
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
- Analyst Ratings
Upturn AI SWOT - About
Retractable Technologies Inc (RVP)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
04/01/2025: RVP (1-star) is currently NOT-A-BUY. Pass it for now.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
AI Based Fundamental Rating
Below Average Performance
These Stocks/ETFs, based on Upturn Advisory, often underperform the market, warranting careful consideration before investing.
Analysis of Past Performance
Type Stock | Historic Profit -43.81% | Avg. Invested days 31 | Today’s Advisory PASS |
Upturn Star Rating | Upturn Advisory Performance  2.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 04/01/2025 |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 17.55M USD | Price to earnings Ratio - | 1Y Target Price - |
Price to earnings Ratio - | 1Y Target Price - | ||
Volume (30-day avg) 39729 | Beta 2.06 | 52 Weeks Range 0.56 - 1.22 | Updated Date 03/31/2025 |
52 Weeks Range 0.56 - 1.22 | Updated Date 03/31/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) -0.53 |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Revenue by Geography
Geography revenue - Year on Year
Earnings Date
Report Date 2025-03-27 | When Before Market | Estimate - | Actual - |
Profitability
Profit Margin -46.71% | Operating Margin (TTM) -95.58% |
Management Effectiveness
Return on Assets (TTM) -4.48% | Return on Equity (TTM) -18.91% |
Valuation
Trailing PE - | Forward PE - | Enterprise Value -14096424 | Price to Sales(TTM) 0.65 |
Enterprise Value -14096424 | Price to Sales(TTM) 0.65 | ||
Enterprise Value to Revenue 0.14 | Enterprise Value to EBITDA 0.5 | Shares Outstanding 29937200 | Shares Floating 13220848 |
Shares Outstanding 29937200 | Shares Floating 13220848 | ||
Percent Insiders 56.27 | Percent Institutions 8.07 |
Analyst Ratings
Rating - | Target Price - | Buy - | Strong Buy - |
Buy - | Strong Buy - | ||
Hold - | Sell - | Strong Sell - | |
Strong Sell - |
Upturn AI SWOT
Retractable Technologies Inc
Company Overview
History and Background
Retractable Technologies, Inc. was founded in 1994. It is dedicated to inventing, developing, manufacturing, and marketing safety medical devices with the goal of preventing needlestick injuries and bloodborne infections.
Core Business Areas
- Safety Syringes: Manufactures and sells VanishPointu00ae and EasyPointu00ae safety syringes designed to prevent accidental needlestick injuries. This is their core revenue driver.
- Safety Needles: Offers VanishPointu00ae safety needles for use with standard syringes, also designed to minimize needlestick risk.
Leadership and Structure
Thomas J. Shaw is the Founder, CEO, and President. The company has a standard corporate structure with a board of directors overseeing operations.
Top Products and Market Share
Key Offerings
- VanishPointu00ae Syringes: Safety syringes that automatically retract the needle into the syringe barrel after use, preventing needlestick injuries. Market share data is not publicly available with precise numbers, but the company competes with larger players. Competitors include Becton Dickinson (BDX), and Smiths Medical. Revenue data specific to this product line is not disaggregated publicly.
- VanishPointu00ae Needles: Safety needles designed for use with luer lock syringes. They automatically retract into the syringe hub, again preventing needlestick injuries. Market share data is not publicly available with precise numbers, but the company competes with larger players. Competitors include Becton Dickinson (BDX), and Smiths Medical. Revenue data specific to this product line is not disaggregated publicly.
Market Dynamics
Industry Overview
The medical safety device industry is driven by regulations aimed at preventing needlestick injuries, healthcare worker safety concerns, and the need to reduce the transmission of bloodborne pathogens. Demand is influenced by hospital budgets, infection control protocols, and government mandates.
Positioning
Retractable Technologies is a niche player focused on safety syringes and needles with a retracting mechanism. Their competitive advantage lies in their patented technology and commitment to safety. However, they face competition from larger companies with broader product portfolios.
Total Addressable Market (TAM)
The global safety syringe market is estimated to be in the billions of dollars. Retractable Technologies holds a small, but focused share of this market. Their TAM is significantly impacted by their ability to gain market share in the retractable safety syringe segment.
Upturn SWOT Analysis
Strengths
- Patented retractable needle technology
- Focus on safety and prevention of needlestick injuries
- Established customer base in healthcare facilities
- Strong brand recognition within its niche
Weaknesses
- Smaller scale compared to major competitors
- Limited product diversification
- Dependence on specific safety regulations and market adoption
- Variable profitability
Opportunities
- Expanding global market for safety medical devices
- Increased regulatory mandates for safety protocols
- Partnerships with larger medical device companies
- New product development in related safety areas
Threats
- Intense competition from larger, more established companies
- Price pressure from competitors
- Changes in healthcare regulations or reimbursement policies
- Potential patent infringement or challenges to their technology
Competitors and Market Share
Key Competitors
- BDX
- SMIT
Competitive Landscape
Retractable Technologies faces a highly competitive landscape dominated by larger companies with extensive resources. To compete effectively, they must focus on niche markets, innovation, and strategic partnerships. Their retractable technology gives them an edge in specific situations.
Major Acquisitions
Growth Trajectory and Initiatives
Historical Growth: Historical growth has been cyclical and dependent on major contracts and regulatory changes.
Future Projections: Future projections are subject to considerable uncertainty and depend on market adoption of safety syringes and competitive pressures.
Recent Initiatives: Recent initiatives likely focus on expanding sales channels and securing new contracts.
Summary
Retractable Technologies is a niche player in the safety syringe market with patented technology. Its core strength is its retractable needle technology, offering an advantage in preventing needlestick injuries. However, the company faces intense competition from larger players and must focus on strategic partnerships and market expansion. Future growth will depend on their ability to gain market share and navigate regulatory changes. Recent initiatives likely focus on securing contracts and expanding sales channels.
Similar Companies
- BDX
- SMIT
- MMM
Sources and Disclaimers
Data Sources:
- Company filings, Industry reports, Market research reports
Disclaimers:
The information provided is for informational purposes only and should not be considered financial advice. Market share data are estimates and may vary. Past performance is not indicative of future results.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Retractable Technologies Inc
Exchange NYSE MKT | Headquaters Little Elm, TX, United States | ||
IPO Launch date 2001-05-04 | Founder, Chairman, President & CEO Mr. Thomas J. Shaw | ||
Sector Healthcare | Industry Medical Instruments & Supplies | Full time employees - | Website https://www.retractable.com |
Full time employees - | Website https://www.retractable.com | ||
Retractable Technologies, Inc. designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession in the United States, rest of North and South America, and internationally. The company offers VanishPoint insulin syringes; tuberculin, insulin, and allergy antigen syringes; small diameter tube adapters; blood collection tube holders; allergy trays; IV safety catheters; Patient Safe syringes and Luer Caps; VanishPoint blood collection sets; EasyPoint needles; and VanishPoint autodisable syringes. It distributes its products through general line and specialty distributor; international distributors; and a direct marketing network. Retractable Technologies, Inc. was incorporated in 1994 and is headquartered in Little Elm, Texas.
Upturn is now on iOS and Android!
Experience Upturn on your mobile. Install it now!
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.